Profound Medical PROF Gain (Loss), Foreign Currency Transaction, before Tax
Gain (Loss), Foreign Currency Transaction, before Tax at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's gain (loss), foreign currency transaction, before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's gain (loss), foreign currency transaction, before tax?
- Profound Medical (PROF) reported gain (loss), foreign currency transaction, before tax of $616K in Q1 2026.
- How has Profound Medical's gain (loss), foreign currency transaction, before tax changed year-over-year?
- Profound Medical's gain (loss), foreign currency transaction, before tax increased by 1521.1% year-over-year, from $38K to $616K.
- What is the long-term trend for Profound Medical's gain (loss), foreign currency transaction, before tax?
- Over 2 years (2023 to 2025), Profound Medical's gain (loss), foreign currency transaction, before tax has grown at a 92.7% compound annual growth rate (CAGR), from -$575K to -$2.14M.